Profile: Cello Group plc (CLL.L)
CLL.L on London Stock Exchange
49.00GBp
8 May 2013
49.00GBp
8 May 2013
Price Change (% chg)
0.75p (+1.55%)
0.75p (+1.55%)
Prev Close
48.25p
48.25p
Open
48.25p
48.25p
Day's High
50.00p
50.00p
Day's Low
47.90p
47.90p
Volume
480,570
480,570
Avg. Vol
159,487
159,487
52-wk High
58.00p
58.00p
52-wk Low
30.00p
30.00p
Cello Group plc, and its subsidiaries, provides research, consulting and direct marketing services. The Company operates in two groups: Research and Consulting, and Tangible. The Research and Consulting Division provides both qualitative and quantitative research to clients across a range of sectors. Tangible offers direct communication solutions. The Tangible segment focuses on direct, digital and data areas. On March 22, 2011, the Company MedErgy HealthGroup Inc. (MedErgy), a healthcare communications consulting company. On April 11, 2011, the Company acquired the Red Kite Consulting Group Limited, a pharmaceutical consulting company. In 2012, the Company launched a pharmaceutical analytics business, Cello Business Sciences, offering a suite of bespoke analytical tools for marketing directors in the pharmaceutical industry. In January 2013, the Company acquired Mash Health Limited and Mash Health Inc (Mash).
Company Address
Cello Group plc
11-13 Charterhouse Buildings
LONDON EC1M 7AP
P: +4420.78128460
F: +4420.72535376
Company Web Links
| Name | Compensation |
|---|---|
Allan Rich |
50,000 |
Mark Scott |
370,000 |
Mark Bentley |
278,000 |
Stephen Highley |
-- |
William David |
-- |

